Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives

by Yang, Jingyan, Liu, Rongzhe, Ektare, Varun, Stephens, Jennifer, Shelbaya, Ahmed
Published in Appl Health Econ Health Policy (2021)

Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus

by Lopez, Janice M.S., Macomson, Brian, Ektare, Varun, Patel, Dipen, Botteman, Marc
Published in Am Health Drug Benefits (2015)

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patie...

by Aletaha, Daniel, Snedecor, Sonya J, Ektare, Varun, Xue, Mei, Bao, Yanjun, Garg, Vishvas
Published in Clinicoecon Outcomes Res (2017)